Direct expression of a growth-promoting peptide hormone, somatomedin C/insulin -like growth factor I, which is quite difficult due to the instability of somatomedin C itself in Escherichia coli, has been achieved by the use of a two-cistron system. As suming that basic somatomedin C might be stabilized by forming a complex with an acidic polypeptide, we constructed synthetic genes consisting of two cistrons; an acidic 93-amino-acid polypeptide was coded in the first cistron followed by a synthetic somatomedin C gene in the second cistron.
The chain termination codon for the first polypeptide overlapped the initiation codon for the second polypeptide in the intercistronic region, as occurs in the polycistronic E. coli tryptophan operon, whose products are associated in multi-subunit enzyme complexes.
In the expres sion of the resulting genetic system, recombinant somatomedin C associated with the acidic polypeptide was accumulated to high levels in the cells. After treatment of the product with acetic acid to dissociate the two components, the recombinant somatomedin C was isolated in a yield of 4.0mg from a liter of culture broth at A600= 1.6. It was determined to be Met-somatomedin C by chymotryptic mapping as well as amino-terminal analysis.
Somatomedin
C, also called insulin-like growth factor-I, is a basic polypeptide hormone consisting of 70 amino acid residues, and is found in human serum (1) (2) (3) (4) (5) (6) .
It shows growth-promoting effects on fibroblasts and cartilage cells and hypoglycemic actions in rats (7, 8) . Therefore it is desirable for the therapy of dwarfism, osteoporosis, skin burns, and bleeding ulcers. The direct expression of a synthetic somatomedin C gene in Escherichia coli HB1.01 was quite insufficient because of the insta bility of the synthesized somatomedin C in the cells, as reported previously (9, 10). Buell et al. also investigated the direct expression, and found that the amount of somatomedin C accumulated in E. coli was influenced by mutations at two chromosomal loci, Ion and htpR (11) . These re-suits indicate that somatomedin C is rapidly de composed by protease La (12) or other proteases under the control of heat-shock proteins (13) . We have reported the production and isolation of somatomedin C (9, 10) and a-human atrial natriuretic polypeptide (submitted for publication) by the use of a fused protein method.
In that work, we applied the idea that the yield of a basic and small polypeptide in E. coli might be improved by fusion with an appropriate protective polypep tide to form a neutral fused polypeptide.
How ever, in the fused protein method, chemical or enzymatic degradation of the resultant fused poly peptide is necessary to recover the target polypep tide hormone.
Thus, we decided to apply the above idea to the synthesis of a polypeptide complex (associated polypeptide) in which basic somatomedin C might be stabilized by association with another acidic polypeptide in E. coli cells. In this paper we describe the construction and expression of genes for somatomedin C associated with the acidic polypeptide.
We also describe the isolation and characterization of Met-somatomedin C. Construction of Expression Vectors-Both of the starting plasmids pLHSdMmtrp (9) and pCLaHtrp3t (submitted for publication) have been described elsewhere. Oligodeoxyribonucleotides were synthesized manually according to the re ported method (14) . All DNA manipulations were performed essentially as described by Maniatis et al. (15) . The preparation of the synthetic genes from the corresponding DNA oligomers was per formed with T4 DNA ligase and T4 polynucleo tide kinase in a similar manner to that reported elsewhere (9, 10) . The constructed plasmids were characterized by restriction endonuclease digestion as well as DNA sequencing by use of the Maxam-Gilbert method (16 and has an acidic pI (5.18, calculated value). The total amino acid and nucleotide sequences for the two-cistron system are shown in Fig. 2 . The AGGA sequence in the 1st cistron is the Shine-Dalgarno sequence for the 2nd cistron, and the TAATG sequence between the 1st and 2nd cistron is the chain termination codon overlapping the subsequent initiation codon. lar proteins, respectively (Fig. 4a, lane 2) , as deter mined with an SDS-PAGE scanner. Both of the products were recovered as cellular insoluble proteins and no 7.7K-band was found in the PBS-soluble portion (Fig. 4a, lanes 3, 4) . These observations indicate that somatomedin C is ag gregated and co-precipitated with the 10K poly peptide in the cells.
MATERIALS AND METHODS

Materials
Isolation Direct expression by the use of two contigu ouse genes was employed for the synthesis of bovine growth hormone by Schoner et al. (21) . They converted the gene for a derivative of bovine growth hormone containing 8 additional amino terminal residues to a two-cistron system coding Met-bovine growth hormone in the 2nd cistron.
They suggested that the translational efficiency of We conclude that the synthesis of heterogene ous associated proteins can be achieved by the use of a two-cistron system having an internal Shine-Dalgarno sequence in the 1st cistron and a chain termination codon overlapping the initiation codon of the 2nd cistron.
The optimization of the inter nal Shine-Dalgarno sequence or the nucleotide se quence from the Shine-Dalgarno region to the sub sequent ATG codon, or another chain termination codon overlapping the subsequent initiation codon (e.g. TGATG or ATGA) may increase the yield of the gene product in the 2nd cistron.
